Most Recent

People who report having enjoyed amphetamine are more likely to have gene variants associated with protection against attention deficit-hyperactivity disorder and schizophrenia, a study shows.

0 Comments

image: Week in Review: March 31–April 4

Week in Review: March 31–April 4

By | April 4, 2014

Transcriptional landscape of the fetal brain; how a parasitic worm invades plants; difficulties reproducing “breakthrough” heart regeneration method; oxytocin and dishonesty

1 Comment

image: The Right to Not Know

The Right to Not Know

By | April 2, 2014

Patients should be able to decline learning about incidental genetic findings when undergoing whole-genome screens, according to new expert recommendations.

1 Comment

image: An Ancient Evolutionary Advantage?

An Ancient Evolutionary Advantage?

By | April 1, 2014

Shared sequences within the brain lipid-metabolism pathway between Neanderthals and modern Europeans highlight questions about how these genetic similarities arose.

3 Comments

image: Commander of an Immune Flotilla

Commander of an Immune Flotilla

By | April 1, 2014

With much of his early career dictated by US Navy interests, Carl June drew inspiration from malaria, bone marrow transplantation, and HIV in his roundabout path to a breakthrough in cancer immunotherapy.

1 Comment

image: Contributors

Contributors

By | April 1, 2014

Meet some of the people featured in the April 2014 issue of The Scientist.

0 Comments

image: Fighting Cancer with Nanomedicine

Fighting Cancer with Nanomedicine

By | April 1, 2014

Nanotechnology-based therapeutics will revolutionize cancer treatment.

2 Comments

image: Getting Down to Business

Getting Down to Business

By | April 1, 2014

Is there a genetic component to entrepreneurial success?

2 Comments

image: Search and Destroy

Search and Destroy

By | April 1, 2014

Turning a patient’s immune cells into cancer-fighting weapons

0 Comments

image: Stem Cells Off the Line

Stem Cells Off the Line

By | April 1, 2014

Researchers work to improve the efficiency of cell therapy manufacturing, while developing procedures to ensure consistent quality.      

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech